Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Charles Gorman Insider Profile
4 Followers
Kevin Charles Gorman, CEO, Director at Neurocrine, holds 11.05K shares in Xencor (Ticker: XNCR), holds 514.60K shares in Neurocrine (Ticker: NBIX).
Kevin Charles Gorman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin Charles Gorman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin Charles Gorman
Kevin Charles Gorman's Trading History
Neurocrine
Feb 15, 2024
CEO, Director
Uninformative Sell
376.68K
$70.84M
Xencor
Jun 17, 2024
Director
Uninformative Buy
―
$209.10K
List of latest transactions for each holding click on a transaction to see Kevin Charles Gorman's performance on stock
You May Also Like
Kevin Charles Gorman insider profile FAQ
What is the percentage of profitable transactions made by Kevin Charles Gorman?
The percentage of profitable transactions made by Kevin Charles Gorman is ―.
What is the average return per transaction made by Kevin Charles Gorman?
The average return per transaction made by Kevin Charles Gorman is ―.
What stocks does Kevin Charles Gorman hold?
Kevin Charles Gorman holds: NBIX, XNCR stocks.
What was Kevin Charles Gorman’s latest transaction?
Kevin Charles Gorman latest transaction was an Uninformative Buy of ―.
What was Kevin Charles Gorman's most profitable transaction?
Kevin Charles Gorman’s most profitable transaction was an Informative Buy of XNCR stock on February 15, 2024. The return on the trade was -11.10%.
What is Kevin Charles Gorman's role in Neurocrine?
Kevin Charles Gorman's role in Neurocrine is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.